HIV Alert: Update on the Management of ART in HCV/HIV Coinfection

Listen to downloadable audio from a series of live Webinars by Susanna Naggie, MD, MHS, and David L. Wyles, MD, in which important considerations for managing ART in patients with HCV/HIV coinfection—including guideline recommendations, management of key drug–drug interactions, and potential liver toxicity with some antiretroviral agents—are discussed and audience questions on this subject are addressed.
Format: Audio (.mp3)
File Size: 28.72 MB
Released: August 1, 2016

Listen to downloadable audio from a series of live Webinars by Susanna Naggie, MD, MHS, and David L. Wyles, MD, in which important considerations for managing ART in patients with HCV/HIV coinfection—including guideline recommendations, management of key drug–drug interactions, and potential liver toxicity with some antiretroviral agents—are discussed and audience questions on this subject are addressed. (42 minutes)

Susanna Naggie, MD, MHS, has disclosed that she has received funds for research support from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, and Tacere and consulting fees from Infectious Diseases Society of America and Merck.

David L. Wyles, MD, has disclosed that he has received consulting fees from AbbVie, Bristol-Myers Squibb, Gilead Sciences, and Merck and funds for research support (paid to the University of California Regents) from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Merck, and Tacere.

Acknowledgements

Supported by independent educational grants from
Gilead Sciences
ViiV Healthcare

Related Content

Downloadable slides of key HIV studies presented at IDWeek, HIV Comorbidities Workshop, and HIV Glasgow 2018, reported by Clinical Care Options

Peter Reiss, MD, PhD Babafemi Taiwo, MBBS Released: November 14, 2018

Retrospective analysis of NA-ACCORD finds greater weight gain in treatment-naive adults with HIV infection initiating integrase inhibitors (INSTIs) vs PI- or NNRTI-based ART

Released: November 6, 2018

Watch an HIV expert panel discuss managing HCV infection in MSM, prescribing HIV PrEP to a PWID, and managing CVD in an HIV-infected woman.

W. David Hardy, MD
Program Director
Princy N. Kumar, MD person default Jaimie P. Meyer, MD, MS, FACP Babafemi Taiwo, MBBS
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: June 18, 2018 Expiration: June 17, 2019

CME-certified expert panel discussion on initiating or switching ART in a series of challenging patient cases.

Monica Gandhi, MD, MPH
Program Director
Eric S. Daar, MD Sally Hodder, MD Babafemi Taiwo, MBBS
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.2 Nursing contact hours Pharmacists: 1.25 contact hours (0.13 CEUs) Released: June 15, 2018 Expiration: June 14, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?